RetinAI
AI Healthcare
Ophthalmology AI / retinal imaging and data management
Acquired
RetinAI is a Swiss and U.S.-based AI healthcare company focused on ophthalmology and optometry, building software to collect, organize, and analyze retinal and eye-health data for clinical, research, and pharmaceutical workflows. Its flagship platform, RetinAI Discovery, uses AI to support diagnosis, monitoring, and data management in eye care, and the company was acquired by EssilorLuxottica in October 2025.
Company Details
- Website
- retinai.com
- Headquarters
- Bern, Switzerland
- Founded
- 2017
- Funding
- $14.18M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring